C D Holdsworth|M Atkinson - JoVE Visualize

Showing results (281-290 of 976) with videos related to

Pageof 98

Sort By:

Clinical and Laboratory Haematology|January 1, 1979

The use of Dispholidus typus venom in elucidating the cause of a low prothrombin indexP M Atkinson, M C Kew, A Sayed, et al.

Malaria Journal|January 12, 2023

Unravelling the impact of insecticide-treated bed nets on childhood malaria in MalawiJulie-Anne A Tangena, Donnie Mategula, Luigi Sedda, et al.

Gut|October 1, 1984

Comparison of the Eder-Puestow and Celestin techniques for dilating benign oesophageal stricturesK R Hine, C J Hawkey, M Atkinson, et al.

American Journal of Human Genetics|September 1, 1992

Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagenM C Willing, C J Pruchno, M Atkinson, et al.

Geospatial Health|December 30, 2014

Interpreting predictive maps of disease: highlighting the pitfalls of distribution models in epidemiologyNicola A Wardrop, Matthew Geary, Patrick E Osborne, et al.

The British Journal of Surgery|December 1, 1981

Structural deterioration of prosthetic oesophageal tubes: an in vitro comparison of latex rubber and silicone rubber tubesF J Branicki, A L Ogilvie, M R Willis, et al.

Medical Care|February 15, 2001

Performance of the ACG case-mix system in two Canadian provincesR J Reid, L MacWilliam, L Verhulst, et al.

Alimentary Pharmacology & Therapeutics|January 9, 1999

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator groupJ R Green, J A Gibson, G D Kerr, et al.

Gastroenterology|January 15, 1998

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator GroupJ R Green, A J Lobo, C D Holdsworth, et al.

Tennessee Medicine : Journal of the Tennessee Medical Association|May 21, 2010

Shiga toxin-producing Escherichia coli (STEC) in Tennessee: surveillance and current clinical laboratory practicesSamir S Hanna, Robyn M Atkinson, Timothy F Jones, et al.

Pageof 98

Showing results (281-290 of 976) with videos related to

Sort By:

Pageof 98

Clinical and Laboratory Haematology|January 1, 1979

The use of Dispholidus typus venom in elucidating the cause of a low prothrombin indexP M Atkinson, M C Kew, A Sayed, et al.

Malaria Journal|January 12, 2023

Unravelling the impact of insecticide-treated bed nets on childhood malaria in MalawiJulie-Anne A Tangena, Donnie Mategula, Luigi Sedda, et al.

Gut|October 1, 1984

Comparison of the Eder-Puestow and Celestin techniques for dilating benign oesophageal stricturesK R Hine, C J Hawkey, M Atkinson, et al.

American Journal of Human Genetics|September 1, 1992

Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagenM C Willing, C J Pruchno, M Atkinson, et al.

Geospatial Health|December 30, 2014

Interpreting predictive maps of disease: highlighting the pitfalls of distribution models in epidemiologyNicola A Wardrop, Matthew Geary, Patrick E Osborne, et al.

The British Journal of Surgery|December 1, 1981

Structural deterioration of prosthetic oesophageal tubes: an in vitro comparison of latex rubber and silicone rubber tubesF J Branicki, A L Ogilvie, M R Willis, et al.

Medical Care|February 15, 2001

Performance of the ACG case-mix system in two Canadian provincesR J Reid, L MacWilliam, L Verhulst, et al.

Alimentary Pharmacology & Therapeutics|January 9, 1999

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator groupJ R Green, J A Gibson, G D Kerr, et al.

Gastroenterology|January 15, 1998

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator GroupJ R Green, A J Lobo, C D Holdsworth, et al.

Tennessee Medicine : Journal of the Tennessee Medical Association|May 21, 2010

Shiga toxin-producing Escherichia coli (STEC) in Tennessee: surveillance and current clinical laboratory practicesSamir S Hanna, Robyn M Atkinson, Timothy F Jones, et al.

Pageof 98